Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Kevin S. Boyle$19.2M
Market Cap • 23/04/20241998
(há 26 anos)
2005
(19 years ago)
NASDAQ
Listagem
Houston
Sede • Texas34
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
TCRTSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.